Fleury
Fleury works in prevention, diagnostic and therapeutic medicine.
Launch date
Employees
Market cap
AUD2.5b
Enterprise valuation
AUD3.3b (Public information from Sep 2024)
Share price
BRL16.54 FLRY3.SA
São Paulo São Paulo (HQ)
Financials
Estimates*
BRL | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 3.0b | 3.9b | 4.5b | 6.5b | 7.8b | 8.3b | 8.8b |
% growth | 2 % | 30 % | 15 % | 45 % | 21 % | 7 % | 6 % |
EBITDA | 823m | 1.1b | 1.3b | 1.8b | 2.0b | 2.2b | 2.3b |
% EBITDA margin | 28 % | 27 % | 28 % | 28 % | 26 % | 26 % | 26 % |
Profit | 257m | 350m | 308m | 424m | 671m | 774m | 869m |
% profit margin | 9 % | 9 % | 7 % | 7 % | 9 % | 9 % | 10 % |
EV / revenue | 3.2x | 2.0x | 1.3x | 2.0x | 1.6x | 1.4x | 1.3x |
EV / EBITDA | 11.5x | 7.4x | 4.5x | 7.3x | 6.2x | 5.5x | 5.1x |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | BRL500m | Post IPO Debt | |
Total Funding | - |
Recent News about Fleury
EditInvestments by Fleury
EditACQUISITION by Fleury Apr 2021
ACQUISITION by Fleury May 2022
ACQUISITION by Fleury Oct 2022